• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Senior Vice President Mcquigg Michael Scott converted options into 6,556 units of Common Stock Holding and covered exercise/tax liability with 1,597 units of Common Stock Holding, increasing direct ownership by 22% to 27,931 units (SEC Form 4)

    3/28/25 4:39:47 PM ET
    $HSTM
    Computer Software: Programming Data Processing
    Technology
    Get the next $HSTM alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    McQuigg Michael Scott

    (Last) (First) (Middle)
    500 11TH AVENUE NORTH
    SUITE 1000

    (Street)
    NASHVILLE TN 37203

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HEALTHSTREAM INC [ HSTM ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Senior Vice President
    3. Date of Earliest Transaction (Month/Day/Year)
    03/28/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock Holding 03/28/2025 M 6,556(1) A $0 29,528 D
    Common Stock Holding 03/28/2025 F 1,597(2) D $31.9 27,931 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Share Units $0(3) 03/28/2025 M 1,825 (4) (5) Common Stock 1,825 $0 0 D
    Restricted Share Units $0(3) 03/28/2025 M 1,477 (6) (5) Common Stock 1,477 $0 1,722 D
    Restricted Share Units $0(3) 03/28/2025 M 457 (7) (5) Common Stock 457 $0 1,486 D
    Restricted Share Units $0(3) 03/28/2025 M 336 (8) (5) Common Stock 336 $0 1,904 D
    Restricted Share Units $0(3) 03/28/2025 M 2,461 (9) (5) Common Stock 2,461 $0 5,536 D
    Explanation of Responses:
    1. Shares acquired on vesting of restricted share units.
    2. Shares withheld for payment of tax liability.
    3. Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
    4. The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 17, 2022, 20% vest on March 17, 2023, 30% vest on March 17, 2024, and the remaining 35% vest on March 17, 2025.
    5. Not applicable.
    6. The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 23, 2023, 20% vest on March 23, 2024, 30% vest on March 23, 2025, and the remaining 35% vest on March 23, 2026.
    7. The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 22, 2024, 20% vest on March 22, 2025, 30% vest on March 22, 2026, and the remaining 35% vest on March 22, 2027.
    8. The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 20, 2025, 20% vest on March 20, 2026, 30% vest on March 20, 2027, and the remaining 35% vest on March 20, 2028.
    9. Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on March 23, 2023 for the period January 1, 2022 through December 31, 2022; 20% vest on March 23, 2024 for the period January 1, 2023 through December 31, 2023; 20% vest on March 23, 2025 for the period January 1, 2024 through December 31, 2024; 20% vest on March 23, 2026 for the period January 1, 2025 through December 31, 2025; and 25% vest on March 23, 2027 for the period January 1, 2026 through December 31, 2026. Vesting is determined based on actual performance. The performance criteria for the period January 1, 2024 through December 31, 2024 was achieved; therefore 20% of the awards vested on March 23, 2025.
    /s/ M. Scott McQuigg 03/28/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HSTM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HSTM

    DatePrice TargetRatingAnalyst
    1/3/2024$32.00Overweight
    Barclays
    12/6/2023Mkt Perform
    JMP Securities
    More analyst ratings

    $HSTM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on HealthStream with a new price target

      Barclays initiated coverage of HealthStream with a rating of Overweight and set a new price target of $32.00

      1/3/24 7:52:29 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • JMP Securities initiated coverage on HealthStream

      JMP Securities initiated coverage of HealthStream with a rating of Mkt Perform

      12/6/23 7:55:31 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • Canaccord Genuity reiterated coverage on HealthStream with a new price target

      Canaccord Genuity reiterated coverage of HealthStream with a rating of Hold and set a new price target of $24.00 from $22.00 previously

      4/28/21 10:45:23 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology

    $HSTM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by HealthStream Inc. (Amendment)

      SC 13G/A - HEALTHSTREAM INC (0001095565) (Subject)

      2/13/24 5:06:13 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • SEC Form SC 13G filed by HealthStream Inc.

      SC 13G - HEALTHSTREAM INC (0001095565) (Subject)

      2/9/24 9:59:02 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • SEC Form SC 13G/A filed by HealthStream Inc. (Amendment)

      SC 13G/A - HEALTHSTREAM INC (0001095565) (Subject)

      2/9/23 11:22:16 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology

    $HSTM
    Financials

    Live finance-specific insights

    See more
    • HealthStream Announces First Quarter 2025 Results

      HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2025. First Quarter 2025 Revenues of $73.5 million in the first quarter of 2025, up 1.0% from $72.8 million in the first quarter of 2024 Operating income of $4.4 million in the first quarter of 2025, down 23.1% from $5.7 million in the first quarter of 2024 Net income of $4.3 million in the first quarter of 2025, down 17.1% from $5.2 million in the first quarter of 2024 Earnings per share (EPS) of $0.14 per share (diluted) in the first quarter of 2025, down from $0.17 per share (diluted) in the first quarte

      5/5/25 4:30:00 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • HealthStream to Host First Quarter 2025 Earnings Conference Call

      HealthStream, Inc. (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today that it will host a conference call and webcast to discuss its first quarter 2025 financial results on Tuesday, May 6, 2025. The Company's financial results for the first quarter 2025 ended March 31, 2025 will be released after the routine time for the close of the market on Monday, May 5, 2025. HealthStream's first quarter 2025 earnings conference call will begin at 9:00 a.m. Eastern Time on Tuesday, May 6, 2025. Participants may access the conference call live via webcast using this link: Webcast Link Here. To participate via telephone, please register in advance using this

      4/22/25 9:25:00 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • HealthStream Announces Fourth Quarter & Full-Year 2024 Results

      HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the fourth quarter and full-year ended December 31, 2024. Fourth Quarter 2024 Revenues of $74.2 million, up 5.2% from $70.6 million in the fourth quarter of 2023 Operating income of $4.7 million, up 10.2% from $4.3 million in the fourth quarter of 2023 Net income of $4.9 million, up 6.5% from $4.6 million in the fourth quarter of 2023 Earnings per share (EPS) of $0.16 per share (diluted), up from $0.15 per share (diluted) in the fourth quarter of 2023 Adjusted EBITDA1 of $16.2 million, up 1.3% from $16.0 million in the fourth quarte

      2/24/25 4:30:00 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology

    $HSTM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HealthStream Announces Share Repurchase Program

      HealthStream (NASDAQ:HSTM), a leading healthcare technology platform company for workforce solutions, today announced that its Board of Directors has approved a new share repurchase program for the Company's common stock, under which the Company may repurchase up to $25 million of outstanding shares of common stock. Pursuant to the authorization, repurchases may be made from time to time in the open market, including under a Rule 10b5-1 plan, through privately negotiated transactions, or otherwise. In addition, any repurchases under the authorization will be subject to prevailing market conditions, liquidity and cash flow considerations, applicable securities laws requirements (including u

      5/8/25 4:30:00 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • HealthStream Announces First Quarter 2025 Results

      HealthStream, Inc. (the "Company") (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today results for the first quarter ended March 31, 2025. First Quarter 2025 Revenues of $73.5 million in the first quarter of 2025, up 1.0% from $72.8 million in the first quarter of 2024 Operating income of $4.4 million in the first quarter of 2025, down 23.1% from $5.7 million in the first quarter of 2024 Net income of $4.3 million in the first quarter of 2025, down 17.1% from $5.2 million in the first quarter of 2024 Earnings per share (EPS) of $0.14 per share (diluted) in the first quarter of 2025, down from $0.17 per share (diluted) in the first quarte

      5/5/25 4:30:00 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • HealthStream to Host First Quarter 2025 Earnings Conference Call

      HealthStream, Inc. (NASDAQ:HSTM), a leading healthcare technology platform for workforce solutions, announced today that it will host a conference call and webcast to discuss its first quarter 2025 financial results on Tuesday, May 6, 2025. The Company's financial results for the first quarter 2025 ended March 31, 2025 will be released after the routine time for the close of the market on Monday, May 5, 2025. HealthStream's first quarter 2025 earnings conference call will begin at 9:00 a.m. Eastern Time on Tuesday, May 6, 2025. Participants may access the conference call live via webcast using this link: Webcast Link Here. To participate via telephone, please register in advance using this

      4/22/25 9:25:00 AM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology

    $HSTM
    SEC Filings

    See more
    • SEC Form 10-Q filed by HealthStream Inc.

      10-Q - HEALTHSTREAM INC (0001095565) (Filer)

      5/9/25 4:35:39 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • HealthStream Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - HEALTHSTREAM INC (0001095565) (Filer)

      5/8/25 4:40:25 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • HealthStream Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - HEALTHSTREAM INC (0001095565) (Filer)

      5/5/25 4:55:25 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology

    $HSTM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Gordon Frank was granted 418 units of Common Stock Holding (SEC Form 4)

      4 - HEALTHSTREAM INC (0001095565) (Issuer)

      4/16/25 5:31:57 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • Executive Vice President Sousa Michael converted options into 4,933 units of Common Stock Holding and covered exercise/tax liability with 1,419 units of Common Stock Holding, increasing direct ownership by 6% to 65,529 units (SEC Form 4)

      4 - HEALTHSTREAM INC (0001095565) (Issuer)

      3/28/25 4:43:41 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology
    • CFO and SVP Roberts Scott Alexander converted options into 6,556 units of Common Stock Holding and covered exercise/tax liability with 1,597 units of Common Stock Holding, increasing direct ownership by 20% to 29,540 units (SEC Form 4)

      4 - HEALTHSTREAM INC (0001095565) (Issuer)

      3/28/25 4:42:17 PM ET
      $HSTM
      Computer Software: Programming Data Processing
      Technology

    $HSTM
    Leadership Updates

    Live Leadership Updates

    See more
    • HealthStream Announces the Addition of Charles E. Beard, Jr. to the Board of Directors

      HealthStream, Inc. (NASDAQ:HSTM), a leading healthcare technology platform company for workforce solutions, announced today that Charles E. Beard, Jr. has joined its Board of Directors and will serve as a member of the Audit Committee. Mr. Beard brings a wealth of experience from his more than 30-year career, where he has held several executive-level positions. Until his recent retirement in December 2024, he served as Chief Operating Officer at Guidehouse, a global consultancy achieving five-fold growth in five years with annual revenues of approximately $3 billion and over 17,000 employees. Prior to that position, he was a Partner at PwC, working with counsel on investigations of transna

      3/11/25 9:25:00 AM ET
      $FDP
      $HSTM
      Farming/Seeds/Milling
      Consumer Staples
      Computer Software: Programming Data Processing
      Technology